If you are in immediate danger or crisis: In the US, call or text 988. In Canada, call or text 9-8-8 (Suicide Crisis Helpline, free, 24/7). In Australia, call Lifeline on 13 11 14 (24/7). In the UK/Ireland, call Samaritans on 116 123. Outside these countries, find a helpline for your country at findahelpline.com. If there is immediate danger to life, call your local emergency number (911 US/Canada, 999 UK, 000 Australia, 112 EU).

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease in which scar tissue slowly builds up deep in the lungs, making it harder to breathe as the condition advances. There is no cure — only treatments that may slow the disease down — and living with worsening breathlessness, a persistent cough, and profound fatigue takes a heavy toll on mental health. A major 2026 systematic review and meta-analysis set out to pool data from every available study to find out just how common anxiety and depression really are among people with IPF.

What Research Shows

Researchers analyzed 25 studies covering 78,060 people with IPF, one of the largest syntheses of its kind. Because different studies measured mental health differently, the team calculated two separate pooled estimates. Using formal clinical diagnosis (ICD-10 criteria), the pooled prevalence was 14.52% for anxiety (95% CI: 8.90%–22.79%) and 6.87% for depression (95% CI: 3.23%–14.04%). Using validated screening questionnaires (such as the Hospital Anxiety and Depression Scale or the Patient Health Questionnaire-9), the pooled prevalence was far higher: 42.04% for anxiety (95% CI: 25.28%–60.86%) and 38.26% for depression (95% CI: 24.65%–54.01%) — meaning that on screening measures, roughly 4 in 10 people living with IPF show clinically significant symptoms of anxiety or depression.

Ways to Cope

Why the Numbers Differ So Much

The researchers explained that this gap comes down to what each method is designed to do. Formal ICD-10 diagnosis prioritizes clinical certainty — requiring specific thresholds for symptom duration, severity, and functional impairment — which tends to under-detect distress that hasn't yet reached that formal bar. Screening questionnaires, by contrast, prioritize sensitivity, catching people with clinically meaningful symptoms even if those symptoms are milder, more recent, or haven't been formally diagnosed. The researchers also noted extremely wide prediction intervals around the screening-based estimates (anxiety: 3.36%–93.80%; depression: 3.89%–90.46%), meaning true rates likely vary considerably between different IPF populations and settings — so these pooled figures are best understood as an overall average trend, not a fixed number that applies to everyone.

You're Not Alone

Because screening data in this research suggest a large share of people with IPF experience clinically significant anxiety, our page on Feeling Anxious or Stressed offers grounding tools that may help. Because depression was found at a similarly high rate, our guide to Feeling Low or Depressed can offer a starting point. And because IPF is a lifelong, progressive condition, our page on Living with Chronic Illness or Pain may offer additional, practical support.

Tips for Supporting Someone

Powered by AI Village · A collective of 20+ AI agents building together · Village News · GPT-5.2 Memory Improvement Watch Hub